CN115282207A - Spray for treating rhinitis and preparation process thereof - Google Patents
Spray for treating rhinitis and preparation process thereof Download PDFInfo
- Publication number
- CN115282207A CN115282207A CN202210970754.4A CN202210970754A CN115282207A CN 115282207 A CN115282207 A CN 115282207A CN 202210970754 A CN202210970754 A CN 202210970754A CN 115282207 A CN115282207 A CN 115282207A
- Authority
- CN
- China
- Prior art keywords
- parts
- spray
- ethanol
- rhinitis
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 59
- 239000007921 spray Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 241000132012 Atractylodes Species 0.000 claims abstract description 20
- 241000218378 Magnolia Species 0.000 claims abstract description 20
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 12
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 12
- 240000003705 Senecio vulgaris Species 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 229920003081 Povidone K 30 Polymers 0.000 claims abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 10
- 235000011477 liquorice Nutrition 0.000 claims abstract description 10
- 241000758794 Asarum Species 0.000 claims abstract description 5
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 54
- 239000003814 drug Substances 0.000 claims description 27
- 239000000341 volatile oil Substances 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 238000007789 sealing Methods 0.000 claims description 17
- 241001506766 Xanthium Species 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000009670 cang er zi wan Substances 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 10
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 10
- 238000001256 steam distillation Methods 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 9
- 238000000227 grinding Methods 0.000 claims description 9
- 239000008055 phosphate buffer solution Substances 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 7
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 7
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 7
- 241000207929 Scutellaria Species 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 5
- 241000628997 Flos Species 0.000 claims 3
- 238000007605 air drying Methods 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 4
- 238000011112 process operation Methods 0.000 abstract description 2
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 9
- 201000009151 chronic rhinitis Diseases 0.000 description 8
- 206010039085 Rhinitis allergic Diseases 0.000 description 7
- 201000010105 allergic rhinitis Diseases 0.000 description 7
- 201000009240 nasopharyngitis Diseases 0.000 description 7
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 6
- 206010039088 Rhinitis atrophic Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010039101 Rhinorrhoea Diseases 0.000 description 5
- 206010028748 Nasal obstruction Diseases 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 206010028735 Nasal congestion Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003928 nasal cavity Anatomy 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- 210000002850 nasal mucosa Anatomy 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- 206010006784 Burning sensation Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a spray for treating rhinitis and a preparation process thereof, wherein the spray is prepared from 30-50 parts of groundsel, 20-30 parts of fried cocklebur fruit, 15-20 parts of divaricate saposhnikovia root, 10-20 parts of povidone K30, 15-25 parts of magnolia flower, 10 to 30 parts of heartleaf houttuynia herb, 15-25 parts of liquorice, 10-20 parts of baical skullcap root and 5-15 parts of largehead atractylodes rhizome according to a certain proportion. The product not only has good effect on treating rhinitis, but also has the advantages of wide material sources, low cost, simple and convenient process operation and the like.
Description
Technical Field
The invention relates to a spray for treating rhinitis and a preparation process thereof, belonging to the field of traditional Chinese medicines.
Background
Rhinitis, that is, inflammatory disease of nasal cavity, is inflammation of nasal mucosa caused by virus, bacteria, various physicochemical factors and some systemic diseases, and rhinitis can be classified into chronic rhinitis, acute rhinitis, atrophic rhinitis, rhinitis medicamentosa, allergic rhinitis and the like according to symptoms. Although the chronic rhinitis occurs slowly, the chronic rhinitis has long-term intermittent or alternative nasal obstruction, which often causes people to breathe smoothly, dizziness and brain swelling; the nasal cavity and the nasopharynx of the patient with the acute rhinitis have the symptoms of obvious dryness, burning sensation, nasal itching, fever, rhinorrhea and the like, so that the body and mind of the patient are exhausted, the smell is reduced sharply, the patient is dizziness and insomnia, and the life and rest of the patient are seriously influenced; atrophic rhinitis, although it is characterized by slow onset of chronic rhinitis, manifests as marked off-flavor in breathing, lumpy mucous membrane secretion and difficult blowing, accompanied by a small amount of nose bleeding when hard-to-pull out the dry scab; rhinitis medicamentosa is usually caused by long-term use of certain drugs which injure nasal mucosa by patients, and nasal obstruction and nasal discharge are often accompanied by nosebleed. The allergic rhinitis is usually caused by the allergy of patients to the surrounding environment, and with the increase of the pressure of modern life and the complex and changeable environment, such as environmental pollution, extreme weather change, sudden temperature drop and the like, more and more people suffer from rhinitis, especially the allergic rhinitis and the chronic rhinitis are prominent, so that the research and development of the rhinitis drug with good treatment effect has wide market prospect.
The existing rhinitis treatment medicines are divided into two types, namely traditional Chinese medicines and western medicines, most of which are spray formulation products, the western medicines not only have the characteristics of quick drug effect, obvious acute inflammation relieving effect and the like, but also have the advantages of few types of formula medicines, easily controlled drug concentration, low cost and the like, but most of the western medicines are hormone medicines, have large side effect and are not easy to use for a long time. Although traditional Chinese medicines have the advantages of small side effect, high cure rate after long-term use and the like, the traditional processing technology has low medicine acquisition rate and slow medicine effect, and most of the traditional Chinese medicines are relatively expensive Chinese herbal medicines, so that the cost is relatively high. Therefore, by combining the characteristics of the traditional Chinese medicine and the western medicine, the product develops the spray for treating rhinitis and the preparation process thereof, and the product not only has good treatment effect on the rhinitis, but also has the advantages of wide material sources, low cost, simple and convenient process operation and the like.
Disclosure of Invention
The invention aims to provide a spray for treating rhinitis.
Yet another object of the present invention is to: provides a preparation process of the spray for treating rhinitis.
The purpose of the invention is realized by the following scheme: a spray for treating rhinitis comprises, by weight, 30-50 parts of groundsel, 20-30 parts of fried cocklebur fruit, 15-20 parts of divaricate saposhnikovia root, 10-20 parts of povidone K30, 15-25 parts of magnolia flower, 10 to 30 parts of heartleaf houttuynia herb, 15-25 parts of liquorice, 10-20 parts of baical skullcap root and 5-15 parts of largehead atractylodes rhizome.
The invention also provides a preparation process of the spray for treating rhinitis, which comprises the following steps:
1) Cleaning the groundsel, the fried cocklebur fruit, the divaricate saposhnikovia root, the magnolia flower, the heartleaf houttuynia herb, the liquoric root, the baical skullcap root and the largehead atractylodes rhizome in the above dosage, drying in the air and grinding into powder; then, the user can use the device to perform the operation,
2) Adopting a steam distillation method to obtain volatile oil of magnolia flower and bighead atractylodes rhizome for later use, and reserving dregs of a decoction;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2), the ethanol extract obtained in the step 3) and povidone K30 dissolved in 85% ethanol under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the compound rhinitis spray.
Is prepared from 30-50 parts of groundsel, 20-30 parts of fried cocklebur fruit, 15-20 parts of divaricate saposhnikovia root, 10-20 parts of povidone K30, 15-25 parts of magnolia flower, 10 to 30 parts of heartleaf houttuynia herb, 15-25 parts of liquoric root, 10-20 parts of baical skullcap root and 5-15 parts of largehead atractylodes rhizome according to a certain proportion. Firstly, cleaning and airing the groundsel, the fried cocklebur fruit, the divaricate saposhnikovia root, the magnolia flower, the houttuynia cordata, the liquorice, the scutellaria baicalensis and the bighead atractylodes rhizome in the above dosage, grinding into powder, then obtaining volatile oil of the magnolia flower and the bighead atractylodes rhizome by adopting a steam distillation method for later use, and reserving dregs of a decoction; soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; then the residual medicine dregs are merged and boiled for 30 min, filtered to remove dregs, cooled, and then added with the volatile oil obtained by distillation, ethanol extract and povidone K30 dissolved by 85 percent ethanol under stirring, and then the pH value is adjusted to 6.0 to 6.5 by phosphate buffer solution, and finally the mixture is subpackaged into bottles, sealed and sterilized to obtain the rhinitis re-spraying agent.
The invention relates to a spray for treating rhinitis and a preparation process thereof, wherein the medicament has greatly increased extraction rate and concentration of active ingredients in the Chinese medicament by means of steam distillation, ethanol leaching and the like, the selected Chinese medicinal materials are safe and have no side effect, the material is widely available, the cost is lower, the spray which is convenient to use and better to absorb is prepared by combining a modern process, and the spray has good treatment effects on chronic rhinitis, acute rhinitis, atrophic rhinitis, drug rhinitis, allergic rhinitis and the like.
Drawings
FIG. 1 is a schematic view of the process.
Detailed Description
Example 1
The rhinitis compound spray is prepared by the following steps as shown in a flow chart 1:
1) Respectively grinding 30 parts of groundsel, 20 parts of fried cocklebur fruit, 15 parts of divaricate saposhnikovia root, 15 parts of magnolia flower, 10 parts of houttuynia cordata, 15 parts of liquorice, 10 parts of scutellaria baicalensis and 10 parts of bighead atractylodes rhizome into powder; then, the user can use the device to perform the operation,
2) Adopting a steam distillation method to obtain volatile oil of magnolia flower and bighead atractylodes rhizome for later use, and reserving dregs of a decoction;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2), the ethanol extract obtained in the step 3) and povidone K30 dissolved in 85% ethanol under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the compound rhinitis spray.
Example 2
The rhinitis compound spray is prepared by the following steps as shown in a flow chart 1:
1) Respectively grinding 30 parts of groundsel, 20 parts of fried cocklebur fruit, 15 parts of divaricate saposhnikovia root, 15 parts of magnolia flower, 10 parts of houttuynia cordata, 15 parts of liquorice, 10 parts of scutellaria baicalensis and 10 parts of bighead atractylodes rhizome into powder; then, the user can use the device to perform the operation,
2) Adopting a steam distillation method to obtain volatile oil of magnolia flower and bighead atractylodes rhizome for later use, and reserving dregs of a decoction;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2) and the ethanol extract in the step 3) under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the rhinitis compound spray.
Example 3
The rhinitis compound spray is prepared by the following steps as shown in a flow chart 1:
1) Respectively grinding 50 parts of groundsel, 30 parts of fried cocklebur fruit, 20 parts of divaricate saposhnikovia root, 25 parts of magnolia flower, 30 parts of houttuynia cordata, 25 parts of liquorice, 20 parts of scutellaria baicalensis and 15 parts of bighead atractylodes rhizome into powder; then, the user can use the device to perform the operation,
2) Adopting a steam distillation method to obtain volatile oil of magnolia flower and bighead atractylodes rhizome for later use, and reserving dregs of a decoction;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2), the ethanol extract obtained in the step 3) and povidone K30 dissolved in 85% ethanol under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the compound rhinitis spray.
Clinical examination
In order to verify the treatment effect of the medicine on various types of rhinitis, clinical experiments are carried out on the medicine
Test object
According to the sorting standard, 10 patients with chronic rhinitis, acute rhinitis, atrophic rhinitis, rhinitis medicamentosa and allergic rhinitis are respectively selected to use the product spray, 3 times a day and continuously for one month.
Sorting standard of chronic rhinitis patients: intermittent or alternate nasal obstruction for a long time, people are not smooth in breathing and dizziness;
sorting standard of acute rhinitis patients: the nasal cavity and the nasopharynx have obvious symptoms of dryness, burning sensation, itching, fever, rhinorrhea and the like;
sorting standard of atrophic rhinitis patients: breath has obvious peculiar smell, mucous membrane secretion is formed into blocks and is not easy to blow out, and when dry scab is forcibly pulled out, the symptoms of small amount of nose bleeding and the like are accompanied;
sorting standard of patients with drug-induced rhinitis: patients take certain medicines which injure nasal mucosa for a long time, and the symptoms of nasal obstruction, nasal discharge, nosebleed and the like are often accompanied;
sorting standard of allergic rhinitis patients: sneezing, watery nasal discharge, and sensitivity to sudden drop of temperature;
the rhinitis spray has the following treatment results:
in the experiment, patients with acute rhinitis, atrophic rhinitis, drug rhinitis and allergic rhinitis are completely cured, 10 patients with acute rhinitis are obviously improved, 8 patients are completely cured, and 2 patients are changed into slight symptoms. The result shows that the rhinitis spray has good curative effect on various types of rhinitis, and the product has obvious effect on treating the rhinitis.
Claims (7)
1. A spray for treating rhinitis is characterized in that: comprises 30-50 parts of groundsel, 20-30 parts of fried cocklebur fruit, 15-20 parts of divaricate saposhnikovia root, 115-25 parts of magnolia flower, 10-30 parts of heartleaf houttuynia herb, 15-25 parts of liquorice, 10-20 parts of baical skullcap root and 5-15 parts of largehead atractylodes rhizome by weight.
2. The spray for treating rhinitis according to claim 1, wherein: also comprises 0-20 parts of polyvidone K30.
3. A process for preparing the spray for treating rhinitis according to claim 1, which is characterized in that:
1) Cleaning herba Senecionis Scandentis, parched fructus Xanthii, radix Saposhnikoviae, flos Magnoliae, herba Houttuyniae, glycyrrhrizae radix, scutellariae radix, and Atractylodis rhizoma, air drying, and grinding into powder; then, the user can use the device to perform the operation,
2) Adopting a steam distillation method to obtain volatile oil of magnolia flower and bighead atractylodes rhizome for later use, and reserving dregs of a decoction;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2), the ethanol extract in the step 3) and povidone K30 dissolved in 85% ethanol under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully and uniformly mixing, subpackaging into bottles, sealing and sterilizing to obtain the compound rhinitis spray.
4. A process for preparing the spray for treating rhinitis according to claim 3, wherein: when the product is prepared, volatile oil of magnolia flower and bighead atractylodes rhizome is obtained by a distillation method, and active ingredients of the medicine are extracted from other herbal medicines by an ethanol leaching method.
5. The process for preparing the spray for treating rhinitis according to claim 3 or 4, wherein: comprises the following steps:
1) Respectively grinding 30 parts of groundsel, 20 parts of fried cocklebur fruit, 15 parts of divaricate saposhnikovia root, 15 parts of magnolia flower, 10 parts of houttuynia cordata, 15 parts of liquorice, 10 parts of scutellaria baicalensis and 10 parts of bighead atractylodes rhizome into powder; then, the user can use the device to perform the operation,
2) Adopting a steam distillation method to obtain volatile oil of magnolia flower and bighead atractylodes rhizome for later use, and reserving dregs of a decoction;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2), the ethanol extract obtained in the step 3) and povidone K30 dissolved in 85% ethanol under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the compound rhinitis spray.
6. The process for preparing the spray for treating rhinitis according to claim 3 or 4, wherein: comprises the following steps:
1) Respectively grinding 30 parts of groundsel, 20 parts of fried cocklebur fruit, 15 parts of divaricate saposhnikovia root, 15 parts of magnolia flower, 10 parts of houttuynia cordata, 15 parts of liquorice, 10 parts of scutellaria baicalensis and 10 parts of bighead atractylodes rhizome into powder; then, the user can use the device to perform the operation,
2) Obtaining volatile oil of flos Magnoliae and Atractylodis rhizoma by steam distillation, and keeping the residue;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2) and the ethanol extract in the step 3) under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the rhinitis compound spray.
7. The process for preparing the spray for treating rhinitis according to claim 3 or 4, wherein: comprises the following steps:
1) Respectively grinding 50 parts of groundsel, 30 parts of fried cocklebur fruit, 20 parts of divaricate saposhnikovia root, 25 parts of magnolia flower, 30 parts of houttuynia cordata, 25 parts of liquorice, 20 parts of scutellaria baicalensis and 15 parts of bighead atractylodes rhizome into powder; then, the user can use the device to perform the operation,
2) Obtaining volatile oil of flos Magnoliae and Atractylodis rhizoma by steam distillation, and keeping the residue;
3) Soaking Concha Haliotidis, parched fructus Xanthii, radix Saposhnikoviae, herba Houttuyniae, glycyrrhrizae radix, and Scutellariae radix powder in 60% ethanol container, sealing, keeping at 40 deg.C, shaking in dark for 1 day to obtain ethanol extractive solution; after that time, the user can use the device,
4) And (3) combining the residual medicine residues, decocting in water for 30 min, filtering to remove residues, cooling, sequentially adding the volatile oil obtained by distillation in the step 2), the ethanol extract obtained in the step 3) and povidone K30 dissolved in 85% ethanol under stirring, adjusting the pH to 6.0-6.5 by using a phosphate buffer solution, fully mixing uniformly, and finally subpackaging into bottles, sealing and sterilizing to obtain the rhinitis compound spray.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210970754.4A CN115282207A (en) | 2022-08-13 | 2022-08-13 | Spray for treating rhinitis and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210970754.4A CN115282207A (en) | 2022-08-13 | 2022-08-13 | Spray for treating rhinitis and preparation process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115282207A true CN115282207A (en) | 2022-11-04 |
Family
ID=83830871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210970754.4A Pending CN115282207A (en) | 2022-08-13 | 2022-08-13 | Spray for treating rhinitis and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115282207A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810726A (en) * | 2010-03-30 | 2010-08-25 | 广东药学院 | Chinese medicinal preparation for treating chronic rhinosinusitis and preparation method thereof |
| CN105560372A (en) * | 2016-03-22 | 2016-05-11 | 泰山医学院 | Traditional Chinese medicine spray for treating rhinitis and preparation method thereof |
| CN105878385A (en) * | 2014-11-20 | 2016-08-24 | 李漩 | Traditional Chinese medicine recipe for treating allergic rhinitis |
| CN108186735A (en) * | 2018-03-22 | 2018-06-22 | 达麒好生物科技（武汉）有限公司 | A kind of spray for treating rhinitis and preparation method thereof |
| CN110327386A (en) * | 2019-08-01 | 2019-10-15 | 长沙曙光医疗科技有限公司 | A kind of spray for treating rhinitis and preparation method thereof |
| CN112089752A (en) * | 2020-10-21 | 2020-12-18 | 山东药品食品职业学院 | Nasopharynx soothing biological spray and preparation method thereof |
-
2022
- 2022-08-13 CN CN202210970754.4A patent/CN115282207A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810726A (en) * | 2010-03-30 | 2010-08-25 | 广东药学院 | Chinese medicinal preparation for treating chronic rhinosinusitis and preparation method thereof |
| CN105878385A (en) * | 2014-11-20 | 2016-08-24 | 李漩 | Traditional Chinese medicine recipe for treating allergic rhinitis |
| CN105560372A (en) * | 2016-03-22 | 2016-05-11 | 泰山医学院 | Traditional Chinese medicine spray for treating rhinitis and preparation method thereof |
| CN108186735A (en) * | 2018-03-22 | 2018-06-22 | 达麒好生物科技（武汉）有限公司 | A kind of spray for treating rhinitis and preparation method thereof |
| CN110327386A (en) * | 2019-08-01 | 2019-10-15 | 长沙曙光医疗科技有限公司 | A kind of spray for treating rhinitis and preparation method thereof |
| CN112089752A (en) * | 2020-10-21 | 2020-12-18 | 山东药品食品职业学院 | Nasopharynx soothing biological spray and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| "鼻通一号治疗鼻炎279例报告", 新医学 * |
| 崔小莲;侯世东;王霞;: "鼻渊康口服液及鼻炎滴剂的制备和临床应用", 中国现代应用药学 * |
| 王振荣: "鼻炎净滴鼻剂的制备及临床应用", 中国医院药学杂志 * |
| 颜成杰: "鼻炎净喷雾剂的制备与临床应用", 江西中医药 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111298123A (en) | Antiviral composition and application thereof in resisting human influenza virus and avian influenza virus | |
| CN116115673A (en) | Traditional Chinese medicine formula for clearing heat and freeing nose and preparation process | |
| CN104524273A (en) | Preparation method of Yinqiao preparation | |
| CN113559207A (en) | Traditional Chinese medicine composition for clearing lung, eliminating phlegm, relieving cough and asthma and application thereof | |
| CN115282207A (en) | Spray for treating rhinitis and preparation process thereof | |
| CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
| CN107050278B (en) | Traditional Chinese medicine aqua for treating pneumonia and asthma as well as preparation method and device thereof | |
| CN105327103A (en) | Medicine composition for treating rhinitis and nasosinusitis and preparation method of medicine composition | |
| CN105663649A (en) | Traditional Chinese medicine composition for treating pharyngitis and preparation method thereof | |
| CN105343847A (en) | Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof | |
| CN105169338A (en) | Medicine composition for treating female climacteric syndromes and preparation method thereof | |
| CN105797092B (en) | Yiyuan anti-cold mixture | |
| CN105435162B (en) | Traditional Chinese medicine composition for treating allergic rhinitis, preparation method and traditional Chinese medicine preparation | |
| CN103623232A (en) | Traditional Chinese medicine for treating trachitis | |
| CN102579663A (en) | Chinese medicinal composition for treating wind-heat type common cold and preparation method thereof | |
| CN116421684B (en) | Traditional Chinese medicine atomization compound preparation for treating xerostomia and preparation method thereof | |
| CN102600285B (en) | Complex propolis composition for treating infectious atrophic rhinitis of pigs and preparation method thereof | |
| CN109157632B (en) | Formula and preparation method of granules for treating epigastric pain | |
| CN105770552A (en) | Chinese herba preparation containing folium artemisiae argyi and used for treating prostatitis and preparing method thereof | |
| CN105998832B (en) | A kind of Chinese medicine composition and its preparation method and application | |
| CN105998979A (en) | Traditional Chinese medicine composition for treating lung-and-kidney-yin-deficiency-type chronic pharyngitis and method | |
| CN105456447A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof | |
| CN104491363A (en) | Traditional Chinese medicine atomization inhalant for treating chronic pharyngitis and preparation method thereof | |
| CN105395710A (en) | Folium artemisiae argyi-containing traditional Chinese medicine preparation for treating fundus hemorrhage and preparing method thereof | |
| CN104666468A (en) | Pharmaceutical composition for treating hyperthyroidism and scrofula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221104 |